SG
GILD icon

Societe Generale’s Gilead Sciences GILD Stock Holding History

Societe Generale’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$7.69M Buy
+1,539,300
New +$137M 0.05% 274

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Societe Generale's GILD Position: Q2 2016 in Review

Societe Generale opened a new position in Gilead Sciences (GILD) in Q2 2016: 121,890 shares worth $10.2M. The stake represents 0.07% of the portfolio and ranks #201 among its holdings.

1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Societe Generale held 121,890 shares of Gilead Sciences worth $10.2M as of Q2 2016.
  • Gilead Sciences was a new Societe Generale position in Q2 2016.
  • Gilead Sciences made up 0.07% of Societe Generale's portfolio in Q2 2016, its #201 holding.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.